how to treat hr breast cancer with dr. virginia kaklamani | onc brothers
Published 4 months ago • 3.3K plays • Length 21:03Download video MP4
Download video MP3
Similar videos
-
1:00
2nd line treatment options for hr breast cancer.
-
0:59
your preference for cdk4/6 inhibitor for metastatic hr breast cancer?
-
0:55
role of chemotherapy in early hormone receptor-positive breast cancer
-
22:12
how to treat her2 breast cancer in 2024 with dr. harold burstein
-
17:11
emerald lead to the elacestrant fda approval - oncbrothers in discussion w/ dr. virginia kaklamani
-
1:00
olaparib or abemaciclib high-risk brca positive breast cancer?
-
35:35
breakthroughs in breast cancer treatment testing
-
0:49
how prevalent are akt pathway alterations in breast cancer?
-
22:08
breast cancer asco 2024 practice changing highlights - discussion with dr. erika hamilton
-
13:51
esmo 2023 breast cancer highlights – keynote 756, tropion-breast01, keynote 52 | onc brothers
-
18:38
how to treat triple negative breast cancer | dr. ruth o'regan chair & dr. anna weiss
-
51:56
new & supporting data for optimizing therapy in her2 breast cancer | dr. kaklamani and dr. o’regan
-
18:44
hr invasive lobular carcinoma management - oncbrothers (rohit & rahul gosain) w/ dr. jason mouabbi
-
0:58
breast cancer trailer asco 2024
-
0:52
rxponder 2024 - amh to determine the benefit of chemotherapy in early breast cancer.
-
10:11
the oncology brothers discuss data presented at asco 2023 on metastatic breast cancer
-
17:08
hormone positive breast cancer algorithm - oncbrothers (rohit & rahul gosain) w/ dr. stephanie graff
-
1:01
what emerald phase iii trial could mean for breast cancer patients | virginia kaklamani, md